Brand differentiation and adoption through a visible step‑change in ease‑of‑use, comfort, and confidence for at‑home self‑injection.
Patient preference and brand loyalty driven by reduced self-administration anxiety through a fully automatic hidden‑needle experience, minimized needle sensation and fewer steps. Aligned with weekly & monthly dose frequency.
Compliance and persistency driven by reduced needle anxiety supporting long‑term therapy success and economic value.
Fully automated U.S. lines in development, DSCSA‑ready serialization, and ISO‑aligned performance underpin reliable supply and surge capacity for large retail and specialty launches. MADE IN THE USA.
